

Artivion secured FDA PMA approval for AMDS, removing IRB hurdles and expanding access for acute aortic dissection patients.
You can purchase shares of Artivion (NYSE:AORT) through any online brokerage.
Other companies in Artivion’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Artivion has a consensus price target of $39.30.
The stock price for Artivion (NYSE: AORT) is $23.58 last updated November 2, 2026 at 4:00 PM EST.
There are no upcoming dividends for Artivion.
Artivion does not have any upcoming earnings scheduled.
There is no upcoming split for Artivion.
Artivion is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among...